212 related articles for article (PubMed ID: 3004693)
1. Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients.
Cohen C; Berson SD
Cancer; 1986 Apr; 57(8):1535-8. PubMed ID: 3004693
[TBL] [Abstract][Full Text] [Related]
2. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong.
Ho JC; Wu PC; Mak TK
Int J Cancer; 1981 Nov; 28(5):571-4. PubMed ID: 6273339
[TBL] [Abstract][Full Text] [Related]
3. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
4. Liver cell dysplasia: association with hepatocellular carcinoma, cirrhosis and hepatitis B antigen carrier status.
Cohen C; Berson SD; Geddes EW
Cancer; 1979 Nov; 44(5):1671-6. PubMed ID: 227574
[TBL] [Abstract][Full Text] [Related]
5. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.
Nakanuma Y; Ohta G
Cancer; 1985 May; 55(10):2400-4. PubMed ID: 2985233
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers.
Okuda K; Nakashima T; Sakamoto K; Ikari T; Hidaka H; Kubo Y; Sakuma K; Motoike Y; Okuda H; Obata H
Cancer; 1982 Feb; 49(3):450-5. PubMed ID: 6277447
[TBL] [Abstract][Full Text] [Related]
7. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
9. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.
Le Bail B; Bernard PH; Carles J; Balabaud C; Bioulac-Sage P
J Hepatol; 1997 Nov; 27(5):835-42. PubMed ID: 9382971
[TBL] [Abstract][Full Text] [Related]
12. Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
Lee HW; Choi GH; Kim DY; Park YN; Kim KS; Choi JS; Ahn SH; Han KH
Oncology; 2017; 93(4):224-232. PubMed ID: 28571030
[TBL] [Abstract][Full Text] [Related]
13. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
Lin CC; Lin CJ; Hsu CW; Chen YC; Chen WT; Lin SM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e146-52. PubMed ID: 17532784
[TBL] [Abstract][Full Text] [Related]
14. Difference in the three-dimensional structure of the sinusoids between hepatocellular carcinoma and cirrhotic liver.
Shimizu H; Suda K; Yokoyama T
Pathol Int; 1996 Dec; 46(12):992-6. PubMed ID: 9110352
[TBL] [Abstract][Full Text] [Related]
15. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma in the noncirrhotic liver.
Smalley SR; Moertel CG; Hilton JF; Weiland LH; Weiand HS; Adson MA; Melton LJ; Batts K
Cancer; 1988 Oct; 62(7):1414-24. PubMed ID: 2843280
[TBL] [Abstract][Full Text] [Related]
17. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers.
Tsujimoto T; Kuriyama S; Yamazaki M; Nakatani Y; Okuda H; Yoshiji H; Fukui H
Int J Oncol; 2001 Jan; 18(1):41-7. PubMed ID: 11115537
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma without cirrhosis in Japanese patients.
Okuda K; Nakashima T; Kojiro M; Kondo Y; Wada K
Gastroenterology; 1989 Jul; 97(1):140-6. PubMed ID: 2542116
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
[TBL] [Abstract][Full Text] [Related]
20. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
